Company intelligence / Profile preview
Sterling Winthrop
- Ownership
- Private
- Employees
- ~27336
- Development stage
- Commercial
Overview
Sterling Winthrop was a major American pharmaceutical company with a long history of drug development and commercialization. It developed several landmark therapies in the early-to-mid twentieth century and had multiple commercialized products by the time it was acquired and broken up in the mid-1990s.
- Therapeutic areas
- CardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Pharma
Drug pipeline
5 assets4 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Sterling Winthrop.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sterling Winthrop.